Funded Tech Companies
Tioma Therapeutics
Tioma Therapeutics, based in St. Louis, has financial backing from SR One Capital Management, Roche Venture Fund and Novo Ventures.
Company Overview
Company Name
Tioma Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
4320 Forest Park Ave. 304
St. Louis, MO 63108
USA
St. Louis, MO 63108
USA
Phone
Website
Email Address
Company Background Information
Overview
Tioma is an immuno-oncology company developing anti-CD47 antibodies for the treatment of solid and hematologic cancers. Our functionally diverse antibodies represent a new class of checkpoint inhibitors that harness both the adaptive and innate immune responses.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/17/2016
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Donovan
Chief Operating Officer
James Stutz
Chief Scientific Officer
Robert Karr
VP - Operations
David Hinds
VP - Product Management
Bradley Keller
VP - R & D
Pamela Manning
Company Investors
- SR One Capital Management
- Roche Venture Fund (Carole Nuechterlein)
- Novo Ventures (Peter Moldt)
- RiverVest Venture Partners (John McKearn)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs